- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00151372
Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients
7. december 2009 opdateret af: Weill Medical College of Cornell University
Treatment Effectiveness in Depressed Patients With Chronic Obstructive Pulmonary Disease
Approximately 20% of patients with chronic obstructive pulmonary disease (COPD) have major depression, a condition that contributes to suffering but also to poor treatment adherence leading to increased disability and morbidity.
This study investigates the effectiveness of a care management intervention aimed at facilitating adherence to a treatment algorithm based on the Agency for Health Care Policy and Research (AHCPR) guidelines.
The investigators hypothesize that this intervention, in comparison to usual care, will increase the prescription of adequate antidepressant treatment by physicians, enhance treatment adherence by patients, and reduce depressive symptoms, suicide ideation, and disability at a 28-week follow-up period.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
141
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
New York
-
West Haverstraw, New York, Forenede Stater, 10993
- Helen Hayes Hospital
-
White Plains, New York, Forenede Stater, 10605
- Weill Medical College of Cornell University
-
White Plains, New York, Forenede Stater, 10605
- Burke Rehabilitation Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
50 år til 95 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Chronic obstructive pulmonary disease by American Thoracic Society criteria
- Major depression by DSM-IV criteria
- 17-item Hamilton score >14
- English speaking
Exclusion Criteria:
- Inability to give informed consent
- MiniMental score <24
- Aphasia
- Nursing home placement after discharge
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Treatment Adherence Intervention
In the Treatment Adherence Intervention group, a study therapist regularly meets with subjects in order to identify obstacles to depression and chronic obstructive pulmonary disease treatment adherence and to help the participant overcome those obstacles.
|
The care management intervention aims at facilitating adherence to a treatment algorithm based on the Agency for Health Care Policy and Research (AHCPR) guidelines.
The investigators hypothesize that this intervention, in comparison to usual care, will increase the prescription of adequate antidepressant treatment by physicians, enhance treatment adherence by patients, and reduce depressive symptoms, suicide ideation, and disability.
|
Aktiv komparator: Enhanced Care
In the Enhanced Care group, physicians providing aftercare will be informed in writing of the patients' diagnosis but will receive no clinical instructions by the research team.
|
For subjects in the Enhanced Care group, physicians providing aftercare will receive no clinical instructions by the research team, but will be informed in writing of the patients' diagnosis and will be provided with a copy of the Agency for Health Care Policy and Research (AHCPR) guidelines for the treatment of depression in primary care with an addendum updating the tables describing Selective Serotonin Reuptake Inhibitors (SSRI) side effect and dosage profiles.
The investigators expect that these physicians will continue to base their practice on clinical judgment about how best to treat depression in chronic obstructive pulmonary disease patients.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Composite Antidepressant Score Scale (CAD)
Tidsramme: 28 Weeks
|
The Composite Antidepressant Score scale (CAD) describes the adequacy of an antidepressant's dosage.
Scores range from 0-4 with 0, 1, and 2 signifying subthreshold or non-adequate therapeutic dosages while 3 and 4 signify a therapeutic/adequate dosage.
The best value is 4 while the worst value is 0.
|
28 Weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Hamilton Depression Rating Scale
Tidsramme: 28 Weeks
|
The 17-item Hamilton Depression Rating Scale (HDRS) measures the severity of a depressive episode: the higher the score, the more severe the depression.
The Best value is 0 and the Worst value is 52.
|
28 Weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: George S Alexopoulos, MD, Weill Medical College of Cornell University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. marts 2002
Primær færdiggørelse (Faktiske)
1. juli 2008
Studieafslutning (Faktiske)
1. juli 2008
Datoer for studieregistrering
Først indsendt
6. september 2005
Først indsendt, der opfyldte QC-kriterier
7. september 2005
Først opslået (Skøn)
8. september 2005
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
11. januar 2010
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
7. december 2009
Sidst verificeret
1. december 2009
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 0201005319
- R01HL071992-05 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Treatment Adherence Intervention
-
Adai Technology (Beijing) Co., Ltd.Ikke rekrutterer endnu
-
Kaiser PermanenteAfsluttet
-
University of GeorgiaMakerere UniversityAfsluttet
-
Stanford UniversityAnonymous DonorRekrutteringAutismespektrumforstyrrelse | Autisme | ASDForenede Stater
-
Washington State UniversityNational Institute on Drug Abuse (NIDA)AfsluttetStofbrugsforstyrrelserForenede Stater
-
University of HaifaAfsluttetPsykologisk intervention | Internet-baseret intervention | InterventionsundersøgelseIsrael
-
SangathAfsluttet
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RekrutteringAutismespektrumforstyrrelse | AutismeForenede Stater
-
Columbia UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University... og andre samarbejdspartnereAfsluttetDepression | HIV/AIDS | Stofbrugsforstyrrelser | Alkoholbrugsforstyrrelse | Post traumatisk stress syndromZambia
-
University of California, San DiegoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) og andre samarbejdspartnereAfsluttet